APO Research

APO RESEARCH · REPORT

Prefilled Syringes Drug

Selected research

Industry Growth & Trends

Global Prefilled Syringes Drug Industry Growth and Trends Forecast to 2032

Market perspective

The global Prefilled Syringes Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Prefilled Syringes Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Prefilled Syringes Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Prefilled Syringes Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Prefilled Syringes Drug include Fresenius Kabi AG, AstraZeneca plc, Amgen Inc., Pfizer, Mylan N.V., Merck & Co. Inc., Novartis AG, Johnson & Johnson and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Prefilled Syringes Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Prefilled Syringes Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Prefilled Syringes Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Prefilled Syringes Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Prefilled Syringes Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Prefilled Syringes Drug Market by Company

Fresenius Kabi AG

AstraZeneca plc

Amgen Inc.

Pfizer

Mylan N.V.

Merck & Co. Inc.

Novartis AG

Johnson & Johnson

Sanofi

Teva Pharmaceutical Industries Ltd.

Prefilled Syringes Drug Segment by Type

Vaccines

Insulin

Adrenaline

Opioids

Others

Prefilled Syringes Drug Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Drug Stores

Prefilled Syringes Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prefilled Syringes Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prefilled Syringes Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prefilled Syringes Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Prefilled Syringes Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Prefilled Syringes Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Vaccines Table 2. Major Company of Insulin Table 3. Major Company of Adrenaline Table 4. Major Company of Opioids Table 5. Major Company of Others Table 6. Global Prefilled Syringes Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Prefilled Syringes Drug Sales by Type (2021-2026) & (K Units) Table 8. Global Prefilled Syringes Drug Sales Market Share in Volume by Type (2021-2026) Table 9. Global Prefilled Syringes Drug Sales by Type (2021-2026) & (US$ Million) Table 10. Global Prefilled Syringes Drug Sales Market Share in Value by Type (2021-2026) Table 11. Global Prefilled Syringes Drug Price by Type (2021-2026) & (US$/Unit) Table 12. Global Prefilled Syringes Drug Sales by Type (2027-2032) & (K Units) Table 13. Global Prefilled Syringes Drug Sales Market Share in Volume by Type (2027-2032) Table 14. Global Prefilled Syringes Drug Sales by Type (2027-2032) & (US$ Million) Table 15. Global Prefilled Syringes Drug Sales Market Share in Value by Type (2027-2032) Table 16. Global Prefilled Syringes Drug Price by Type (2027-2032) & (US$/Unit) Table 17. North America Prefilled Syringes Drug Sales by Type (2021-2026) & (K Units) Table 18. North America Prefilled Syringes Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Prefilled Syringes Drug Sales by Type (2021-2026) & (K Units) Table 20. Europe Prefilled Syringes Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Prefilled Syringes Drug Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Prefilled Syringes Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Prefilled Syringes Drug Sales by Type (2021-2026) & (K Units) Table 24. Latin America Prefilled Syringes Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Prefilled Syringes Drug Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Prefilled Syringes Drug Sales by Type (2021-2026) & (US$ Million) Table 27. Prefilled Syringes Drug Industry Trends Table 28. Prefilled Syringes Drug Industry Drivers Table 29. Prefilled Syringes Drug Industry Opportunities and Challenges Table 30. Prefilled Syringes Drug Industry Restraints Table 31. Global Prefilled Syringes Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Prefilled Syringes Drug Revenue Market Share by Company (2021-2026) Table 33. Global Prefilled Syringes Drug Sales by Company (2021-2026) & (K Units) Table 34. Global Prefilled Syringes Drug Sales Share by Company (2021-2026) Table 35. Global Prefilled Syringes Drug Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Prefilled Syringes Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Prefilled Syringes Drug Major Company Production Sites and Headquarters Table 38. Global Prefilled Syringes Drug Company, Product Type & Application Table 39. Global Prefilled Syringes Drug Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Prefilled Syringes Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Prefilled Syringes Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Prefilled Syringes Drug Sales by Region (2021-2026) & (K Units) Table 44. Global Prefilled Syringes Drug Sales Market Share in Volume by Region (2021-2026) Table 45. Global Prefilled Syringes Drug Sales by Region (2021-2026) & (US$ Million) Table 46. Global Prefilled Syringes Drug Sales Market Share in Value by Region (2021-2026) Table 47. Global Prefilled Syringes Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Prefilled Syringes Drug Sales by Region (2027-2032) & (K Units) Table 49. Global Prefilled Syringes Drug Sales Market Share in Volume by Region (2027-2032) Table 50. Global Prefilled Syringes Drug Sales by Region (2027-2032) & (US$ Million) Table 51. Global Prefilled Syringes Drug Sales Market Share in Value by Region (2027-2032) Table 52. Global Prefilled Syringes Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Prefilled Syringes Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Prefilled Syringes Drug Sales by Application (2021-2026) & (K Units) Table 55. Global Prefilled Syringes Drug Sales Market Share in Volume by Application (2021-2026) Table 56. Global Prefilled Syringes Drug Sales by Application (2021-2026) & (US$ Million) Table 57. Global Prefilled Syringes Drug Sales Market Share in Value by Application (2021-2026) Table 58. Global Prefilled Syringes Drug Price by Application (2021-2026) & (US$/Unit) Table 59. Global Prefilled Syringes Drug Sales by Application (2027-2032) & (K Units) Table 60. Global Prefilled Syringes Drug Sales Market Share in Volume by Application (2027-2032) Table 61. Global Prefilled Syringes Drug Sales by Application (2027-2032) & (US$ Million) Table 62. Global Prefilled Syringes Drug Sales Market Share in Value by Application (2027-2032) Table 63. Global Prefilled Syringes Drug Price by Application (2027-2032) & (US$/Unit) Table 64. North America Prefilled Syringes Drug Sales by Application (2021-2026) & (K Units) Table 65. North America Prefilled Syringes Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Prefilled Syringes Drug Sales by Application (2021-2026) & (K Units) Table 67. Europe Prefilled Syringes Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Prefilled Syringes Drug Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Prefilled Syringes Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Prefilled Syringes Drug Sales by Application (2021-2026) & (K Units) Table 71. Latin America Prefilled Syringes Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Prefilled Syringes Drug Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Prefilled Syringes Drug Sales by Application (2021-2026) & (US$ Million) Table 74. Fresenius Kabi AG Company Information Table 75. Fresenius Kabi AG Business Overview Table 76. Fresenius Kabi AG Prefilled Syringes Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Fresenius Kabi AG Prefilled Syringes Drug Product Portfolio Table 78. Fresenius Kabi AG Recent Development Table 79. AstraZeneca plc Company Information Table 80. AstraZeneca plc Business Overview Table 81. AstraZeneca plc Prefilled Syringes Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. AstraZeneca plc Prefilled Syringes Drug Product Portfolio Table 83. AstraZeneca plc Recent Development Table 84. Amgen Inc. Company Information Table 85. Amgen Inc. Business Overview Table 86. Amgen Inc. Prefilled Syringes Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Amgen Inc. Prefilled Syringes Drug Product Portfolio Table 88. Amgen Inc. Recent Development Table 89. Pfizer Company Information Table 90. Pfizer Business Overview Table 91. Pfizer Prefilled Syringes Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Pfizer Prefilled Syringes Drug Product Portfolio Table 93. Pfizer Recent Development Table 94. Mylan N.V. Company Information Table 95. Mylan N.V. Business Overview Table 96. Mylan N.V. Prefilled Syringes Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Mylan N.V. Prefilled Syringes Drug Product Portfolio Table 98. Mylan N.V. Recent Development Table 99. Merck & Co. Inc. Company Information Table 100. Merck & Co. Inc. Business Overview Table 101. Merck & Co. Inc. Prefilled Syringes Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Merck & Co. Inc. Prefilled Syringes Drug Product Portfolio Table 103. Merck & Co. Inc. Recent Development Table 104. Novartis AG Company Information Table 105. Novartis AG Business Overview Table 106. Novartis AG Prefilled Syringes Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Novartis AG Prefilled Syringes Drug Product Portfolio Table 108. Novartis AG Recent Development Table 109. Johnson & Johnson Company Information Table 110. Johnson & Johnson Business Overview Table 111. Johnson & Johnson Prefilled Syringes Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Johnson & Johnson Prefilled Syringes Drug Product Portfolio Table 113. Johnson & Johnson Recent Development Table 114. Sanofi Company Information Table 115. Sanofi Business Overview Table 116. Sanofi Prefilled Syringes Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Sanofi Prefilled Syringes Drug Product Portfolio Table 118. Sanofi Recent Development Table 119. Teva Pharmaceutical Industries Ltd. Company Information Table 120. Teva Pharmaceutical Industries Ltd. Business Overview Table 121. Teva Pharmaceutical Industries Ltd. Prefilled Syringes Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Teva Pharmaceutical Industries Ltd. Prefilled Syringes Drug Product Portfolio Table 123. Teva Pharmaceutical Industries Ltd. Recent Development Table 124. North America Prefilled Syringes Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 125. North America Prefilled Syringes Drug Sales by Country (2021-2026) & (K Units) Table 126. North America Prefilled Syringes Drug Sales Market Share by Country (2021-2026) Table 127. North America Prefilled Syringes Drug Sales Forecast by Country (2027-2032) & (K Units) Table 128. North America Prefilled Syringes Drug Sales Market Share Forecast by Country (2027-2032) Table 129. North America Prefilled Syringes Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 130. North America Prefilled Syringes Drug Market Size by Country (2021-2026) & (US$ Million) Table 131. North America Prefilled Syringes Drug Market Share by Country (2021-2026) Table 132. North America Prefilled Syringes Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 133. North America Prefilled Syringes Drug Market Share Forecast by Country (2027-2032) Table 134. Europe Prefilled Syringes Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 135. Europe Prefilled Syringes Drug Sales by Country (2021-2026) & (K Units) Table 136. Europe Prefilled Syringes Drug Sales Market Share by Country (2021-2026) Table 137. Europe Prefilled Syringes Drug Sales Forecast by Country (2027-2032) & (K Units) Table 138. Europe Prefilled Syringes Drug Sales Market Share Forecast by Country (2027-2032) Table 139. Europe Prefilled Syringes Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. Europe Prefilled Syringes Drug Market Size by Country (2021-2026) & (US$ Million) Table 141. Europe Prefilled Syringes Drug Market Share by Country (2021-2026) Table 142. Europe Prefilled Syringes Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. Europe Prefilled Syringes Drug Market Share Forecast by Country (2027-2032) Table 144. Asia-Pacific Prefilled Syringes Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 145. Asia-Pacific Prefilled Syringes Drug Sales by Country (2021-2026) & (K Units) Table 146. Asia-Pacific Prefilled Syringes Drug Sales Market Share by Country (2021-2026) Table 147. Asia-Pacific Prefilled Syringes Drug Sales Forecast by Country (2027-2032) & (K Units) Table 148. Asia-Pacific Prefilled Syringes Drug Sales Market Share Forecast by Country (2027-2032) Table 149. Asia-Pacific Prefilled Syringes Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 150. Asia-Pacific Prefilled Syringes Drug Market Size by Country (2021-2026) & (US$ Million) Table 151. Asia-Pacific Prefilled Syringes Drug Market Share by Country (2021-2026) Table 152. Asia-Pacific Prefilled Syringes Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 153. Asia-Pacific Prefilled Syringes Drug Market Share Forecast by Country (2027-2032) Table 154. Latin America Prefilled Syringes Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 155. Latin America Prefilled Syringes Drug Sales by Country (2021-2026) & (K Units) Table 156. Latin America Prefilled Syringes Drug Sales Market Share by Country (2021-2026) Table 157. Latin America Prefilled Syringes Drug Sales Forecast by Country (2027-2032) & (K Units) Table 158. Latin America Prefilled Syringes Drug Sales Market Share Forecast by Country (2027-2032) Table 159. Latin America Prefilled Syringes Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 160. Latin America Prefilled Syringes Drug Market Size by Country (2021-2026) & (US$ Million) Table 161. Latin America Prefilled Syringes Drug Market Share by Country (2021-2026) Table 162. Latin America Prefilled Syringes Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 163. Latin America Prefilled Syringes Drug Market Share Forecast by Country (2027-2032) Table 164. Middle East and Africa Prefilled Syringes Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 165. Middle East and Africa Prefilled Syringes Drug Sales by Country (2021-2026) & (K Units) Table 166. Middle East and Africa Prefilled Syringes Drug Sales Market Share by Country (2021-2026) Table 167. Middle East and Africa Prefilled Syringes Drug Sales Forecast by Country (2027-2032) & (K Units) Table 168. Middle East and Africa Prefilled Syringes Drug Sales Market Share Forecast by Country (2027-2032) Table 169. Middle East and Africa Prefilled Syringes Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 170. Middle East and Africa Prefilled Syringes Drug Market Size by Country (2021-2026) & (US$ Million) Table 171. Middle East and Africa Prefilled Syringes Drug Market Share by Country (2021-2026) Table 172. Middle East and Africa Prefilled Syringes Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 173. Middle East and Africa Prefilled Syringes Drug Market Share Forecast by Country (2027-2032) Table 174. Key Raw Materials Table 175. Raw Materials Key Suppliers Table 176. Prefilled Syringes Drug Distributors List Table 177. Prefilled Syringes Drug Customers List Table 178. Research Programs/Design for This Report Table 179. Authors List of This Report Table 180. Secondary Sources Table 181. Primary Sources List of Figures Figure 1. Prefilled Syringes Drug Image Figure 2. Global Prefilled Syringes Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prefilled Syringes Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Prefilled Syringes Drug Sales (2021-2032) & (K Units) Figure 5. Vaccines Image Figure 6. Global Vaccines Sales YoY Growth (2021-2032) & (K Units) Figure 7. Insulin Image Figure 8. Global Insulin Sales YoY Growth (2021-2032) & (K Units) Figure 9. Adrenaline Image Figure 10. Global Adrenaline Sales YoY Growth (2021-2032) & (K Units) Figure 11. Opioids Image Figure 12. Global Opioids Sales YoY Growth (2021-2032) & (K Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Prefilled Syringes Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Prefilled Syringes Drug Market Share by Type 2025 VS 2032 Figure 17. North America Prefilled Syringes Drug Sales Market Share in Volume by Type in 2025 Figure 18. North America Prefilled Syringes Drug Sales Market Share in Value by Type in 2025 Figure 19. Europe Prefilled Syringes Drug Sales Market Share in Volume by Type in 2025 Figure 20. Europe Prefilled Syringes Drug Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Prefilled Syringes Drug Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Prefilled Syringes Drug Sales Market Share in Value by Type in 2025 Figure 23. Latin America Prefilled Syringes Drug Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Prefilled Syringes Drug Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Prefilled Syringes Drug Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Prefilled Syringes Drug Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Prefilled Syringes Drug Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Retail Pharmacies Image Figure 30. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 31. Online Pharmacies Image Figure 32. Global Online Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 33. Hospital Pharmacies Image Figure 34. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 35. Drug Stores Image Figure 36. Global Drug Stores Sales YoY Growth (2021-2032) & (K Units) Figure 37. Global Prefilled Syringes Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Prefilled Syringes Drug Market Share by Application 2025 VS 2032 Figure 39. North America Prefilled Syringes Drug Sales Market Share in Volume by Application in 2025 Figure 40. North America Prefilled Syringes Drug Sales Market Share in Value by Application in 2025 Figure 41. Europe Prefilled Syringes Drug Sales Market Share in Volume by Application in 2025 Figure 42. Europe Prefilled Syringes Drug Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Prefilled Syringes Drug Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Prefilled Syringes Drug Sales Market Share in Value by Application in 2025 Figure 45. Latin America Prefilled Syringes Drug Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Prefilled Syringes Drug Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Prefilled Syringes Drug Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Prefilled Syringes Drug Sales Market Share in Value by Application in 2025 Figure 49. North America Prefilled Syringes Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. North America Prefilled Syringes Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Prefilled Syringes Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Prefilled Syringes Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Prefilled Syringes Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Europe Prefilled Syringes Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Prefilled Syringes Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Prefilled Syringes Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Prefilled Syringes Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Asia-Pacific Prefilled Syringes Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Prefilled Syringes Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Prefilled Syringes Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Prefilled Syringes Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Latin America Prefilled Syringes Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Prefilled Syringes Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Prefilled Syringes Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Prefilled Syringes Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 66. Middle East and Africa Prefilled Syringes Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Prefilled Syringes Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Prefilled Syringes Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Prefilled Syringes Drug Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Prefilled Syringes Drug Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Vaccines
  • Insulin
  • Adrenaline
  • Opioids
  • Others
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
  • Drug Stores
Companies covered
  • Fresenius Kabi AG
  • AstraZeneca plc
  • Amgen Inc.
  • Pfizer
  • Mylan N.V.
  • Merck & Co. Inc.
  • Novartis AG
  • Johnson & Johnson
  • Sanofi
  • Teva Pharmaceutical Industries Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Prefilled Syringes Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Prefilled Syringes Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Prefilled Syringes Drug Market by Type
  6. 1.3.1 Vaccines
  7. 1.3.2 Insulin
  8. 1.3.3 Adrenaline
  9. 1.3.4 Opioids
  10. 1.3.5 Others
  11. 1.4 Global Prefilled Syringes Drug Market Size by Type
  12. 1.4.1 Global Prefilled Syringes Drug Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Prefilled Syringes Drug Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Prefilled Syringes Drug Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Prefilled Syringes Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Prefilled Syringes Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Prefilled Syringes Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Prefilled Syringes Drug Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Prefilled Syringes Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Prefilled Syringes Drug Industry Trends
  2. 2.2 Prefilled Syringes Drug Industry Drivers
  3. 2.3 Prefilled Syringes Drug Industry Opportunities and Challenges
  4. 2.4 Prefilled Syringes Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Prefilled Syringes Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Prefilled Syringes Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Prefilled Syringes Drug Price (2021-2026)
  4. 3.4 Global Prefilled Syringes Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Prefilled Syringes Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Prefilled Syringes Drug Company, Product Type & Application
  7. 3.7 Global Prefilled Syringes Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Prefilled Syringes Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Prefilled Syringes Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Prefilled Syringes Drug Tier 1, Tier 2, and Tier 3
4 Prefilled Syringes Drug Regional Status and Outlook
  1. 4.1 Global Prefilled Syringes Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Prefilled Syringes Drug Historic Market Size by Region
  3. 4.2.1 Global Prefilled Syringes Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Prefilled Syringes Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Prefilled Syringes Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Prefilled Syringes Drug Forecasted Market Size by Region
  7. 4.3.1 Global Prefilled Syringes Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Prefilled Syringes Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Prefilled Syringes Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Prefilled Syringes Drug by Application
  1. 5.1 Prefilled Syringes Drug Market by Application
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Hospital Pharmacies
  5. 5.1.4 Drug Stores
  6. 5.2 Global Prefilled Syringes Drug Market Size by Application
  7. 5.2.1 Global Prefilled Syringes Drug Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Prefilled Syringes Drug Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Prefilled Syringes Drug Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Prefilled Syringes Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Prefilled Syringes Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Prefilled Syringes Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Prefilled Syringes Drug Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Prefilled Syringes Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Fresenius Kabi AG
  2. 6.1.1 Fresenius Kabi AG Company Information
  3. 6.1.2 Fresenius Kabi AG Business Overview
  4. 6.1.3 Fresenius Kabi AG Prefilled Syringes Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Fresenius Kabi AG Prefilled Syringes Drug Product Portfolio
  6. 6.1.5 Fresenius Kabi AG Recent Developments
  7. 6.2 AstraZeneca plc
  8. 6.2.1 AstraZeneca plc Company Information
  9. 6.2.2 AstraZeneca plc Business Overview
  10. 6.2.3 AstraZeneca plc Prefilled Syringes Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 AstraZeneca plc Prefilled Syringes Drug Product Portfolio
  12. 6.2.5 AstraZeneca plc Recent Developments
  13. 6.3 Amgen Inc.
  14. 6.3.1 Amgen Inc. Company Information
  15. 6.3.2 Amgen Inc. Business Overview
  16. 6.3.3 Amgen Inc. Prefilled Syringes Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Amgen Inc. Prefilled Syringes Drug Product Portfolio
  18. 6.3.5 Amgen Inc. Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Prefilled Syringes Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Prefilled Syringes Drug Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 Mylan N.V.
  26. 6.5.1 Mylan N.V. Company Information
  27. 6.5.2 Mylan N.V. Business Overview
  28. 6.5.3 Mylan N.V. Prefilled Syringes Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Mylan N.V. Prefilled Syringes Drug Product Portfolio
  30. 6.5.5 Mylan N.V. Recent Developments
  31. 6.6 Merck & Co. Inc.
  32. 6.6.1 Merck & Co. Inc. Company Information
  33. 6.6.2 Merck & Co. Inc. Business Overview
  34. 6.6.3 Merck & Co. Inc. Prefilled Syringes Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Merck & Co. Inc. Prefilled Syringes Drug Product Portfolio
  36. 6.6.5 Merck & Co. Inc. Recent Developments
  37. 6.7 Novartis AG
  38. 6.7.1 Novartis AG Company Information
  39. 6.7.2 Novartis AG Business Overview
  40. 6.7.3 Novartis AG Prefilled Syringes Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Novartis AG Prefilled Syringes Drug Product Portfolio
  42. 6.7.5 Novartis AG Recent Developments
  43. 6.8 Johnson & Johnson
  44. 6.8.1 Johnson & Johnson Company Information
  45. 6.8.2 Johnson & Johnson Business Overview
  46. 6.8.3 Johnson & Johnson Prefilled Syringes Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Johnson & Johnson Prefilled Syringes Drug Product Portfolio
  48. 6.8.5 Johnson & Johnson Recent Developments
  49. 6.9 Sanofi
  50. 6.9.1 Sanofi Company Information
  51. 6.9.2 Sanofi Business Overview
  52. 6.9.3 Sanofi Prefilled Syringes Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Sanofi Prefilled Syringes Drug Product Portfolio
  54. 6.9.5 Sanofi Recent Developments
  55. 6.10 Teva Pharmaceutical Industries Ltd.
  56. 6.10.1 Teva Pharmaceutical Industries Ltd. Company Information
  57. 6.10.2 Teva Pharmaceutical Industries Ltd. Business Overview
  58. 6.10.3 Teva Pharmaceutical Industries Ltd. Prefilled Syringes Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Teva Pharmaceutical Industries Ltd. Prefilled Syringes Drug Product Portfolio
  60. 6.10.5 Teva Pharmaceutical Industries Ltd. Recent Developments
7 North America by Country
  1. 7.1 North America Prefilled Syringes Drug Sales by Country
  2. 7.1.1 North America Prefilled Syringes Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Prefilled Syringes Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Prefilled Syringes Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Prefilled Syringes Drug Market Size by Country
  6. 7.2.1 North America Prefilled Syringes Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Prefilled Syringes Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Prefilled Syringes Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Prefilled Syringes Drug Sales by Country
  2. 8.1.1 Europe Prefilled Syringes Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Prefilled Syringes Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Prefilled Syringes Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Prefilled Syringes Drug Market Size by Country
  6. 8.2.1 Europe Prefilled Syringes Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Prefilled Syringes Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Prefilled Syringes Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Prefilled Syringes Drug Sales by Country
  2. 9.1.1 Asia-Pacific Prefilled Syringes Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Prefilled Syringes Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Prefilled Syringes Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Prefilled Syringes Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Prefilled Syringes Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Prefilled Syringes Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Prefilled Syringes Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Prefilled Syringes Drug Sales by Country
  2. 10.1.1 South America Prefilled Syringes Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Prefilled Syringes Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Prefilled Syringes Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Prefilled Syringes Drug Market Size by Country
  6. 10.2.1 South America Prefilled Syringes Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Prefilled Syringes Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Prefilled Syringes Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Prefilled Syringes Drug Sales by Country
  2. 11.1.1 Middle East and Africa Prefilled Syringes Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Prefilled Syringes Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Prefilled Syringes Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Prefilled Syringes Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Prefilled Syringes Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Prefilled Syringes Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Prefilled Syringes Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Prefilled Syringes Drug Value Chain Analysis
  2. 12.1.1 Prefilled Syringes Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Prefilled Syringes Drug Production Mode & Process
  7. 12.2 Prefilled Syringes Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Prefilled Syringes Drug Distributors
  10. 12.2.3 Prefilled Syringes Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research